Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer (Q36072056)

12 August 2017

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer (English)

1 reference

12 August 2017

1 reference

1 reference

Maki Tanioka

3

0 references

Hajime Asahina

object named as

Hajime Asahina

6

0 references

author name string

Yasushi Goto

1

1 reference

12 August 2017

Ikuo Sekine

2

1 reference

12 August 2017

Takashi Shibata

4

1 reference

12 August 2017

Chiharu Tanai

5

1 reference

12 August 2017

Hiroshi Nokihara

7

1 reference

12 August 2017

Noboru Yamamoto

8

1 reference

12 August 2017

Hideo Kunitoh

9

1 reference

12 August 2017

Yuichiro Ohe

10

1 reference

12 August 2017

Hironori Kikkawa

11

1 reference

12 August 2017

Emiko Ohki

12

1 reference

12 August 2017

Tomohide Tamura

13

1 reference

12 August 2017

language of work or name

1 reference

13 July 2011

1 reference

Investigational New Drugs

12 August 2017

1 reference

12 August 2017

30

1 reference

12 August 2017

4

1 reference

12 August 2017

1548-1556

1 reference

Figitumumab (CP-751,871) for cancer therapy

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Development of the monoclonal antibody figitumumab, targeting the insulin-like growth factor-1 receptor, for the treatment of patients with non-small-cell lung cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Disrupting insulin-like growth factor signaling as a potential cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

The role of the IGF system in cancer growth and metastasis: overview and recent insights

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Genetic disorders in the growth hormone - insulin-like growth factor-I axis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Insulin-like growth factors and neoplasia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Expression and function of the insulin-like growth factor I system in human non-small-cell lung cancer and normal lung cell lines

2 October 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9715-4

Phase I dose escalation study of the anti insulin-like growth factor-I receptor monoclonal antibody CP-751,871 in patients with refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9715-4

Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9715-4

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10637-011-9715-4

Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Lifestyle correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3388259

Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21748299

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10637-011-9715-4

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

21748299

1 reference